Sava Secures $8M Funding to Revolutionize Health Monitoring
Sava, a London-based health monitoring company providing a wearable biosensor platform, recently secured $8M in Seed funding. The round was led by Balderton Capital and Exor Ventures. The company plans to utilize the funds to grow its team, enhance its product line manufacturing capability, and showcase the platform’s clinical performance. Sava, founded by Renato Circi and Rafael Michali, is focused on developing a wearable biosensor platform that can detect molecules just under the skin. Its innovative microsensor technology enables the monitoring of biomarkers in the body in real-time, with a particular emphasis on glucose levels.
The startup has received approval from the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) to move forward with clinical trials involving patients with diabetes.
This milestone will enable Sava to further validate its revolutionary technology on a larger scale. Sava's microsensor offers pain-free, real-time insights for users, with an upcoming clinical study set to kick off with collaborators from the Universities of Oxford and Cambridge. By leveraging key partnerships and regulatory approvals, Sava is positioning itself as a leader in the digital health space, providing actionable data to improve health outcomes.
With the financial backing from Balderton Capital and Exor Ventures, Sava is well-equipped to advance its wearable biosensor platform and revolutionize health monitoring. The company's focus on developing a user-friendly, yet impactful technology sets it apart in the market. Through ongoing clinical trials and collaboration with esteemed research institutions, Sava is poised to make significant strides in the health tech sector. As Sava continues to innovate and expand its reach globally, it is set to transform the way individuals monitor and manage their health, ultimately improving overall well-being.
They've invested in Sava
Get to know these Healthtech investors
Click here for a full list of 6,528+ startup investors in the UK